Please login to the form below

Not currently logged in
Email:
Password:

lung cancer

This page shows the latest lung cancer news and features for those working in and with pharma, biotech and healthcare.

AstraZeneca and Daiichi Sankyo receive FDA approval for lung cancer drug

AstraZeneca and Daiichi Sankyo receive FDA approval for lung cancer drug

A phase 2 trial demonstrated an overall response rate of 57.7% in patients with non-small cell lung cancer. ... AZ and Daiichi Sankyo also announced promising results from its joint phase 1b trial assessing datopotamab deruxtecan (Dato-DXd) in patients

Latest news

More from news
Approximately 130 fully matching, plus 875 partially matching documents found.

Latest Intelligence

More from intelligence
Approximately 1 fully matching, plus 62 partially matching documents found.

Latest appointments

More from appointments
Approximately 0 fully matching, plus 12 partially matching documents found.

Latest from PMHub

  • Ad tracking: the end of the road? Ad tracking: the end of the road?

    2. such as:. Health causes (e.g. ‘Lung cancer awareness’, ‘World Diabetes Day’, ‘Chemotherapy’).

  • Can tobacco companies really reinvent themselves as healthcare companies? Can tobacco companies really reinvent themselves as healthcare companies?

    But can tobacco companies reinvent themselves as healthcare companies? Since smoking was linked to serious diseases such as lung cancer in the 1950s, health experts have been focused on influencing consumer ... Vectura has also been highly criticised for

  • Cancer: Beyond the Backlog Cancer: Beyond the Backlog

    Not all cancers are equal, some have seen much more progress than others: for example brain, pancreatic, lung and oesaphageal cancer have all seen limited improvement in outcomes and there is ... We should be reinvigorating transformative ambitions for

  • Why you should feel optimistic about the future of healthcare Why you should feel optimistic about the future of healthcare

    Precision medicines already exist; imatinib works to treat leukaemia only when the cancer cells have a particular genetic makeup, Sotorasib targets a specific mutation in people with lung cancer to halt

  • The heavy toll of COVID-19 on cancer patients

    During the COVID-19 pandemic, oncology treatments paused while cancer continued to spread. ... The therapy works predominantly on non-small cell lung cancer. The NHS has also rolled out four chemo-buses which allowed patients to take part in therapy

More from PMHub
Approximately 3 fully matching, plus 20 partially matching documents found.

Subscribe to our email news alerts

Featured jobs

PMHub

Add my company
Dovetail

We’re a specialist health consultancy that supports companies, healthcare professionals and patients to work hand in hand with a common...

Latest intelligence

Sustainability
Environment: where does the pharmaceutical industry stand?
...
The communication challenge of helping he next generation to be healthier
As the pressure on the health service increases the health of the next generation is vital for everyone. How do we show positive attitudes and change behaviour while future proofing...
Are we losing sight of what the democratisation of healthcare really looks like?
We have a core responsibility as healthcare communicators to consistently drive for better inclusion, engagement and compliance. What does the ‘democratisation of healthcare’ really look like?...